Carnicom’s Report of Artificial Red Blood Cells in Morgellons
Clifford Carnicom has caught us with not knowing what to think in his latest research artificial blood update on his web site @
”ARTIFICIAL BLOOD (?)
Clifford E Carnicom
Aug 27 2009
Strong evidence now exists that an artificial or modified blood form is a dominant internal component, if not the dominant component, of dental filament samples that are commonly associated with the Morgellons condition.”
He sent the samples out to two different testing labs and got a positive result from both of hematology being present and is using a Hemastik blood present testing device, which is also showing positive when applied to experiment samples.
There are thousands of patents which show that we have been able to create artificial red blood cells for a while now, here are a few below. Note that this first one is a baculoviral artificial red blood cells suggested use in influenza vaccines:
The Red Wine Test Day 1
I decided to see what I produced by swishing some red wine in my mouth and spit it directly into to Petri Dish with nutrient agar, I see where Carnicom is using blood agar.
Below are my first series of photographs at 100x, I see right away there are what I am calling baculoviral capsids, and what Carnicom is calling, red blood cells in the specimen.
I used red wine only, no peroxide. As far as I know, the inside of my mouth is not bleeding and is in fairly good dental health. I did not leave the big chunks of the material in the dish, only smaller ones, so that I could photograph it easily:
How Artificial Blood Works
However, additional research has led to several specific blood substitutes in two classes — hemoglobin-based oxygen carriers (HBOCs) and perflourocarbons (PFCs).
One HBOC, called MP4, is made from hemoglobin coated in polyethylene glycol.
Unlike HBOCs, PFCs are usually white and are entirely synthetic. They’re a lot like hydrocarbons — chemicals made entirely of hydrogen and carbon — but they contain fluorine instead of carbon. 
From 2004 to 2006, Northfield Laboratories began testing an HBOC called PolyHeme on trauma patients. The study took place at more than 20 hospitals around the United States. Since many trauma patients are unconscious and can’t give consent for medical procedures, the Food and Drug Administration (FDA) approved the test as a no-consent study. In other words, doctors could give patients PolyHeme instead of real blood without asking first. 
Patients given artificial blood 23 October, 2003
”Doctors have for the first time successfully used artificial blood to treat patients.
The product is a powder which can be stored for years, say scientists at Stockholm’s Karolinska Hospital.
It is made from donated supplies of real blood, which normally has a shelf-life of just 42 days.
The powder can then be mixed into liquid form when needed, and used immediately regardless of the patient’s blood type.
The synthetic blood has been developed by researchers in the US – the exact process for developing it has been kept secret – and it has been tested for the first time on eight patients at Karolinska Hospital. ” 
Some of the artificial bloods on the market today:
OxygentTM is an intravascular oxygen carrier in clinical development as a temporary "blood substitute" to reduce or eliminate the need for donor blood transfusions during surgery. OxygentTM is the only form of perflourocarbon currently on the market. It is licensed only for veterinary use and is undergoing stage III trials in humans. It is an emulsion of perflourocarbons and
a lecithin membrane. 
In such form stabilised haemoglobin (diaspirin cross-linked haemoglobin, DCLHb; trade name HemAssist; Baxter Healthcare Corp) reached Phase III clinical trials. This is the most widely studied of the haemoglobin-based blood substitutes, used in more than a dozen animal and clinical studies.
Hemolink (Hemosol, Inc., Missiassauga, Canada) is a haemoglobin solution that contains cross-linked an o-rafinose polymerised human haemoglobin which is currently in Phase II trials in cardiothoracic surgery in USA. Previous conducted Phase III in Canada demonstrated the effectiveness of Hemolink as substitute to conventional transfusion in cardio surgery patients.
Hemopure and Biopure
Two additional cross-linked polymers of bovine (Hemopure, Biopure, Cambridge, MA) and human (PolyHeme, Northfield Laboratories, Inc.) origin have been used in trials during cardiac and abdominal surgery as well as in trauma patients.
OxyVita Hb is a polymerised HBOC developed at the University of Maryland, Baltimore and undergoing pre-clinical studies in the United States. Polymerisation is via a novel synthetic process involving the linkage of activated carboxyl groups with lysyl residues, to form a so-called "zero-linked" polymerised haemoglobin lacking chemical residues. The zero-linked polymerisation process can be applied to a wide variety of mammalian haemoglobins.
One other form of HBOCs (hemoglobin based oxygen carriers) is encapsulated haemoglobin. In the 1950s, the first form of encapsulated haemoglobin was developed but limited technical possibility and absence of public interest slowed further development until the HIV crisis.
In the 1980s, an HBOC was developed by the US Army at the Letterman Army Institute of Research (LAIR) which did not need typing. However, in clinical trials the HBOC were proven to be problematic, with more deaths using the HBOC than in the control group. Yet, their use would be of value to sustain the wounded in military conflicts. 
There is mention of a study done where polymerized bovine hemoglobin solution was given as a replacement for allogeneic red blood cell transfusion after cardiac surgery in this Science Direct article.
One solution was to use a modified form of the chemical used by our own red blood cells, hemoglobin. Natural hemoglobin decays within hours from a tetramer protein into a dimer, which is useless and highly toxic to the liver. Researchers have tried to chemically stabilize hemoglobin or to encapsulate it within artificial red blood cells.
All forms of modified hemoglobin yet produced have an exceptionally short lifespan in the human bloodstream – the best achievement is with artificial red blood cells that have a half-life of about 20 hours.
Below is an animation movie of a respirocyte (an artificial red blood cell) being injected into the bloodstream. This looks very similar to what we are seeing in samples:
Each respirocyte can store and transport 236 times more oxygen than natural red blood cells. It can also monitor carbon acidity in the cell.
Theorist Robert Freitas has proposed respirocytes as a superior alternative to naturally occurring red blood cells, and has similarly proposed "microbivore" robots that would attack pathogens in the manner of white blood cells.
By definition, respirocytes qualify as nanotechnology, a field of technology still in the early phases of development. Considerations involved in building respirocytes include power, immune reaction or toxicity, computation and communication, and social issues such as economics.
Because respirocytes and related technologies would, if successful, improve the user’s abilities beyond normal human limits, their design is associated with the Transhumanism movement which seeks such advances. 
”Robert A. Freitas Jr. is a Senior Research Fellow, one of four researchers at the nonprofit foundation Institute for Molecular Manufacturing in Palo Alto, California. He holds a 1974 Bachelor’s degree majoring in both physics and psychology from Harvey Mudd College, and a 1978 Juris Doctor (J.D.) degree from Santa Clara University. He has written more than 150 technical papers, book chapters, or popular articles on a diverse set of scientific, engineering, and legal topics. He co-edited the 1980 NASA feasibility analysis of self-replicating space factories and later authored the first detailed technical design study of a hypothetical medical nanorobot ever published in a refereed medical journal. ”
A Paper on Respirocytes by Robert Frietas
A respirocyte preferentially mechanically extracts oxygen from its environment and stores it, pressurized. It can do the same with carbon dioxide and so can perform same role that blood does in its course through the body. It has computational capability, design redundancy, communication capability; uses glucose in the blood for energy, etc. .
The purposed artificial Respirocyte is a spherical nanomedical device 1 micron in diameter made up of a flawless diamond or sapphire shell constructed atom by atom. This device moves gas molecules into and out of small, pressurized vessels. There are molecular sorting rotors with binding sites known as pockets that are exposed along the rim to adhere to a specific molecule when exposed to the plasma. The bonding site rotates to expose the interior chamber and the bound molecules are forcibly ejected by rods and stored in tanks. The Respirocite is powered by a motor which generates mechanical energy by combining glucose and oxygen .
Aren’t We Seeing Respirocytes in Our Samples?
Below are earlier published photos of what I believe resembles a respirocyte that is being seen in human samples that Carnicom is calling a ‘red blood cell’ and that I am calling a ‘baculovirus capsid’:
Day 2 of The Red Wine
Day 2’s observation shows capsids and spheres forming:
And lots of cellular activity inside this piece:
It seems strange that a technology that isn’t even developed yet is inside of us?
Red Wine Test – Day 3
I can’t tell that much is happening other than a few good-sized spheres are developing:
Red Wine Test – Day 4
A sphere has split:
I can’t tell that the cells in this area are getting any larger, I would have to do a comparison to day 1 or 2 to see…
Comparison to Day 2…
No, I don’t notice any significant change in the inner cell size from Day 2 to Day 4.
The Culturing of Red Wine
Not to take away from Carnicom, I think any help we get at this juncture is a God-send, but I happened to notice something tonight that might affect culturing red wine. I have a fungus gnat infestation in my home that I can’t seem to get under control, this has been on-going now for a while and realize that it is probably due to how my washing machine is leaking onto the wood under the house, a long story…
Anyway, I am devising ways to trap the two endless gnats in my environment with fine china glasses of red wine set out. In one glass I have a cheap wine, which invariably a fungus is growing in two separate rooms… this fungus looks exactly like that in Carnicom’s photos @ http://www.carnicom.com/blood2.htm
I am thinking that since there is possibly a fungal agent added into the wine-making process to create this fungal variable in his Petri Dish growth and that by him having the red wine in the dish, this is too much of a variable in regard as to what is truly going on inside of Morgellons. I am seeing the exact same growth in my trap glasses of wine set out for the gnats to climb into and drown!
What is odd is that a glass of a more expensive wine, that has been out the same amount of time, is not growing this green-tipped fungus.
I took a piece of the growth in the wine glass out and put it in a Petri Dish to see if our familiar objects show up. I noticed that this piece of fungus was very thick and not able to photograph because of its thickness. I am hoping that its outer edges might show some familiarity to what we have seen in the past in the next day or so?
I am also noting that Carnicom is using a blood agar and this medium would not allow him to photograph into, such as I do with the clear-ish agar that I use.
Fungus From Red Wine
Here are photos of the outer edges of a piece of fungus removed from a glass of standing red wine and that piece put into a Petri Dish with nutrient agar @100x… after 2 days growth:
We can see the biofilm spheres starting to form out of the fungus:
Back to my samples in red wine – Day 5:
It appears as if the carbon capsids are becoming larger, I will do a comparison next:
To see if the size of the capsids are changing, here is a comparison from Day 2 to Day 5. I took an easily identifiable piece to use as an example:
10/15/09 @100x, three days growth:
We can start to see a small amount of growth happening in the capsid size.
The piece of fungus removed from the standing wine glass is Morg-like, the fungus is green in color with red and blue hyphae.
Day 9, We can see the micelles or liposomes are growing in size:
This piece of red wine/saliva swish that has the cells in it have grown very little, Day 9:
As compared to Day 2:
A new creation coming out of a sphere or is the red wine sample producing the spheres?
In the meantime, the piece of fungus that was in a glass of red wine is starting to grow the red and blue hyphaed green fungus, this is Day 5.
These next photos show where the fungus/yeast used in the red wine (cheese, bread, beer…) making process is the Morgellons Mystery Fungus, Day 9:
The yeast most commonly used in certain foods is saccharomyces cerevisiae, this is a Generally Regarded As Safe (GRAS) fungus/yeast and that is why our hospital tests are not showing this fungus in our biopsies or cultures… it is probably not in their data banks to do a comparison to.
. Tracy V. Wilson
. Tsai, Albert. "Nanomedicine – The Medical Revolution." University of Southern California – Technology Commercialization Alliance. 20 Apr. 2005. http://www.usc.edu/org/techalliance/Anthology%202002/Nanomedicine.pdf
No comments yet.
- Morgellons Artifacts Found in Rainwater – Part 1
- Morgellons Researchers
- Morgellons Disease Sufferers Growing Weary in the Wait
- Morgellons Progression Study
- How Morgellons Is Formed
- Morgellons Is Partially the Frog Fungus
- Morgellons Is Zoonotic
- Morgellons ‘Fibers’ Turn Into Spheres
- Our Morgellons Spheres
- The Morgellons "Spaceships"
- A Lot of Fiber in our Diet?
- Cigarette Filter Fiber Study